Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee.

Int J Radiat Oncol Biol Phys

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Published: April 2010

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ijrobp.2009.09.078	DOI Listing

Publication Analysis

stereotactic body

body radiotherapy

radiotherapy primary

primary management

management early-stage

early-stage low-

low- intermediate-risk

intermediate-risk prostate

prostate cancer

cancer report

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!